Published July 24, 2026 | Version 1.0.0

Bioluminate and Osprey data - Highly specific SARS-CoV-2 main protease (Mpro) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based system

Description

Osprey and Bioluminate Raw Data

Files

Bioluminate.zip

Files (39.4 MB)

Name Size
md5:55c9869ef1766a30669d1535a09f7313
9.0 MB Preview Download
md5:00bce2b77546b2d34dacd520069b2538
30.4 MB Preview Download

Additional details

Funding

FWF Austrian Science Fund
Computational identification of drug resistance mutations P34376